Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 20/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 10/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1228594 | 0.89 | REN (0.54) | RENKCNH2CYP3A4 | |
| SCHEMBL3108333 | 0.82 | REN (0.48) | RENKCNH2CYP3A4 | |
| SCHEMBL1518424 | 0.80 | REN (0.69) | RENKCNH2CYP3A4 | |
| SCHEMBL1069755 | 0.80 | REN (0.69) | RENKCNH2CYP3A4 | |
| SCHEMBL1518423 | 0.80 | REN (0.69) | RENKCNH2CYP3A4 | |
| SCHEMBL3096976 | 0.79 | REN (0.45) | RENKCNH2CYP3A4 | |
| SCHEMBL1072238 | 0.79 | REN (0.70) | RENKCNH2CYP3A4 | |
| SCHEMBL1072237 | 0.79 | REN (0.70) | RENKCNH2CYP3A4 | |
| SCHEMBL1229665 | 0.79 | GCK (0.33) | RENKCNH2CYP3A4 | |
| SCHEMBL1229339 | 0.78 | REN (0.46) | RENKCNH2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120190701-A1 | RENIN INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2012-07-26 | — | — | US | disclosed |
| EP-2467385-A1 | RENIN INHIBITORS | Merck Canada Inc. (CA) | 2012-06-27 | — | — | EP | disclosed |
| US-20110237622-A1 | RENIN INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2011-09-29 | — | — | US | disclosed |
| WO-2011020193-A1 | RENIN INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2011-02-24 | — | — | WO | disclosed |
| US-20100249163-A1 | RENIN INHIBITORS | MERCK CANADA INC. (CA) | 2010-09-30 | — | — | US | disclosed |
| US-20100249163-A1 | RENIN INHIBITORS | MERCK CANADA INC. (CA) | 2010-09-30 | — | — | US | disclosed |
| US-20100249163-A1 | RENIN INHIBITORS | MERCK CANADA INC. (CA) | 2010-09-30 | — | — | US | disclosed |
| WO-2009070869-A1 | RENIN INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2009-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110237622-A1 | RENIN INHIBITORS | REN, ACE, ACE2 | REN 1/4885KCNH2 269/4885CYP3A4 129/4885 |
| US-20100249163-A1 | RENIN INHIBITORS | REN, ACE, AGTR1 | REN 1/4885KCNH2 1176/4885CYP3A4 1183/4885 |
| US-20120190701-A1 | RENIN INHIBITORS | REN, ACE, AGTR1 | REN 1/4885KCNH2 35/4885CYP3A4 908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.